Tempus AI announces collaboration with Biontech

  • Tempus AI (NASDAQ:TEM) announced a multi-year collaboration with BioNTech SE (NASDAQ:BNTX) which leverages Tempus’ multimodal datasets in support of BioNTech’s next-generation oncology pipeline.
  • Under this collaboration, Tempus is providing analytical support and computational biology expertise to BioNTech across its comprehensive research

Leave a Reply

Your email address will not be published. Required fields are marked *